FIELD: medicine, dermatology.
SUBSTANCE: invention relates to a method for treatment of atopic dermatitis. Method involves prescribing antihistaminic preparations, disintoxicating therapy, topical glucorticoid ointments and immunomodulating epiphysis hormone melatonin in the dose 3 mg in 21.00 p. m. for 21 days. Method provides the effectiveness of treatment due to reducing the content of immunoglobulin IgE.
EFFECT: improved and enhanced effectiveness of treatment.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ESTIMATING BRONCHIAL ASTHMA SEVERITY DEGREE | 2004 |
|
RU2268001C1 |
METHOD FOR PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN SUFFERING RECURRENT OBSTRUCTIVE BRONCHITIS IN INCREASED BIOLOGICAL MEDIUM CONTAMINATION BY HEAVY METALS AND ALDEHYDES | 2011 |
|
RU2459622C1 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS IN CHILDREN | 2006 |
|
RU2348423C2 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2340348C1 |
METHOD OF TREATING ATOPIC DERMATITIS IN CHILDREN WITH SECONDARY IMMUNODEFICIENCY SYNDROME | 2014 |
|
RU2542421C1 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS (VERSIONS) | 2007 |
|
RU2343914C1 |
METHOD FOR TREATMENT AND PREVENTION OF ALLERGIC SPECTRUM STATES | 2016 |
|
RU2635968C1 |
METHOD OF TREATING ATOPIC DERMATITIS IN CHILDREN WITH DIAGNOSED CYTOMEGALOVIRUS INFECTION | 2007 |
|
RU2402776C2 |
METHOD OF TREATING ECOMODIFIED ATOPIC DERMATITIS IN CHILDREN BEING RESIDENTS OF TECHNOGENIC CHEMICAL ENVIRONMENTS | 2010 |
|
RU2436574C2 |
METHOD FOR TREATING ATOPIC DERMATITIS | 1996 |
|
RU2150306C1 |
Authors
Dates
2006-01-27—Published
2004-02-16—Filed